share_log
Moomoo 24/7 ·  Mar 27 07:05
Atea Pharmaceuticals Completes Patient Enrollment In Global Phase 3 SUNRISE-3 Trial Evaluating Bemnifosbuvir For COVID-19 In High-Risk Patients
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment